Long-term remission of recalcitrant tumour-stage mycosis fungoides following chemotherapy with pegylated liposomal doxorubicin

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 1, 2003, Pages 80-82

  Tsatalas, C ^a   Martinis, G ^a   Margaritis, D ^a   Spanoudakis, E ^a   Kotsianidis, I ^a   Karpouzis, A ^a   Bourikas, G ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Chemotherapy; Cutaneous T cell lymphoma; Mycosis fungoides; Pegylated liposomal doxorubicin

Indexed keywords

ALITRETINOIN; ALPHA INTERFERON; ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; FLUOROURACIL; FOLINIC ACID; GROWTH FACTOR; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; DISEASE DURATION; DISEASE SEVERITY; DRUG FORMULATION; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; FLU LIKE SYNDROME; HUMAN; INFECTION; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROGNOSIS; PUVA; TREATMENT FAILURE;

ADULT; ANTINEOPLASTIC AGENTS; DOXORUBICIN; FEMALE; HUMANS; LIPOSOMES; MYCOSIS FUNGOIDES; REMISSION INDUCTION; SKIN NEOPLASMS;

EID: 0037253563     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00642.x     Document Type: Article

References (8)

1. Diamandidou E, Cohen PR, Kurtzrock R. Mycosis fungoides and Sézary syndrome. Blood 1996; 88: 2385-2409.
2. Kuzel TM, Guitart J, Rosen ST. Cutaneous T-cell lymphomas. In: Hoffman R, Benz EJ Jr, Shattil SJ et al. editors. Hematology. Basic Principles and Practice, 3rd ed. Churchill Livingstone, Philadelphia, 2000: 1372-1387.
3. Wollina U, Graefe T, Karte K. Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin. J Am Acad Dermatol 2000; 42: 40-46.
4. Bunn PJ, Lamberg S. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Report 1979; 63: 725-728.
5. Kim YH, Hoppe RT. Mycosis fungoides and the Sézary syndrome. Sem Oncol 1999; 26: 276-289.
6. Hoppe RT. Mycosis fungoides and other cutaneous lymphomas. In: Canellos GP, Lister TA, Sklar JL, editors. The Lymphomas. W.B. Saunders Company, Philadelphia, 1998: 495-506.
7. Balmer C, Valley AW. Basic principles of cancer treatment and cancer chemotherapy. In: Di Piro JT, Talbert RL, Hayes PE et al. editors. Pharmacotherapy: a Pathophysiologic Approach, 2nd ed. Appleton & Lange, Norwalk Connecticut, 1993: 1879-1929.
8. Coukell AJ, Spencer CM. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Drugs 1997; 53: 520-538.